Xing B - Search Results

1

In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery.

Zhang J, Hao N, Liu W, Lu M, Sun L, Chen N, Wu M, Zhao X, Xing B, Sun W, He F. Zhang J, et al. Among authors: xing b. Br J Cancer. 2017 Nov 21;117(11):1676-1684. doi: 10.1038/bjc.2017.344. Epub 2017 Oct 12. Br J Cancer. 2017. PMID: 29024941 Free PMC article.

2

Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues.

Sun W, Xing B, Sun Y, Du X, Lu M, Hao C, Lu Z, Mi W, Wu S, Wei H, Gao X, Zhu Y, Jiang Y, Qian X, He F. Sun W, et al. Among authors: xing b. Mol Cell Proteomics. 2007 Oct;6(10):1798-808. doi: 10.1074/mcp.M600449-MCP200. Epub 2007 Jul 12. Mol Cell Proteomics. 2007. PMID: 17627933 Free article.

3

Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILAC.

Chen N, Sun W, Deng X, Hao Y, Chen X, Xing B, Jia W, Ma J, Wei H, Zhu Y, Qian X, Jiang Y, He F. Chen N, et al. Among authors: xing b. Proteomics. 2008 Dec;8(23-24):5108-18. doi: 10.1002/pmic.200800280. Proteomics. 2008. PMID: 19016532

4

Characterization of the liver tissue interstitial fluid (TIF) proteome indicates potential for application in liver disease biomarker discovery.

Sun W, Ma J, Wu S, Yang D, Yan Y, Liu K, Wang J, Sun L, Chen N, Wei H, Zhu Y, Xing B, Zhao X, Qian X, Jiang Y, He F. Sun W, et al. Among authors: xing b. J Proteome Res. 2010 Feb 5;9(2):1020-31. doi: 10.1021/pr9009172. J Proteome Res. 2010. PMID: 20038183

5

AIB1 as an independent prognostic marker in hepatocellular carcinoma after hepatic resection.

Song JM, Lu M, Liu FF, Du XJ, Xing BC. Song JM, et al. J Gastrointest Surg. 2012 Feb;16(2):356-60. doi: 10.1007/s11605-011-1762-9. Epub 2011 Nov 4. J Gastrointest Surg. 2012. PMID: 22052107

6

N-WASP is highly expressed in hepatocellular carcinoma and associated with poor prognosis.

Jin KM, Lu M, Liu FF, Gu J, Du XJ, Xing BC. Jin KM, et al. Surgery. 2013 Apr;153(4):518-25. doi: 10.1016/j.surg.2012.08.067. Epub 2012 Dec 4. Surgery. 2013. PMID: 23218879

7

Expression of plasminogen activator inhibitor-2 is negatively associated with invasive potential in hepatocellular carcinoma cells.

Jin Y, Zhou L, Jin KM, Xing BC. Jin Y, et al. Chin Med Sci J. 2013 Mar;28(1):16-9. doi: 10.1016/s1001-9294(13)60013-9. Chin Med Sci J. 2013. PMID: 23527801

8

1B50-1, a mAb raised against recurrent tumor cells, targets liver tumor-initiating cells by binding to the calcium channel α2δ1 subunit.

Zhao W, Wang L, Han H, Jin K, Lin N, Guo T, Chen Y, Cheng H, Lu F, Fang W, Wang Y, Xing B, Zhang Z. Zhao W, et al. Among authors: xing b. Cancer Cell. 2013 Apr 15;23(4):541-56. doi: 10.1016/j.ccr.2013.02.025. Cancer Cell. 2013. PMID: 23597567 Free article.

9

[Surgical outcomes of second liver resections for recurrent hepatic metastases from colorectal cancer].

Liu W, Yan XL, Wang K, Bao Q, Sun Y, Wang HW, Jin KM, Xing BC. Liu W, et al. Zhonghua Yi Xue Za Zhi. 2013 Jul 23;93(28):2183-5. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24169324 Chinese.

10

The outcome of liver resection and lymphadenectomy for hilar lymph node involvement in colorectal cancer liver metastases.

Liu W, Yan XL, Wang K, Bao Q, Sun Y, Xing BC. Liu W, et al. Int J Colorectal Dis. 2014 Jun;29(6):737-45. doi: 10.1007/s00384-014-1863-5. Epub 2014 Apr 18. Int J Colorectal Dis. 2014. PMID: 24743847

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,956 results

Search Page

Filters